Company Profile

SyntaxisBio Inc
Profile last edited on: 1/23/2024      CAGE: 7L3W9      UEI: DSLAGLZJQLT1

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2016
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1755 Wittington Place Suite 345
Farmers Branch, TX 75234
   (210) 562-9062
   N/A
   N/A
Location: Single
Congr. District: 33
County: Dallas

Public Profile

Indicated as founded in 2016 in one source and 2018 in another, SyntaxBio is described as addressing development of a CRISPR/Cas9-based, genetic programming platform designed to address the convertion of cells into biological computers using DNA-based instructions that read like lines of code. SyntaxBio's platform is designed program cells without the need for consistent external intervention

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 1 NIH $389,194
Project Title: Provenance attestation of human cells using physical unclonable functions

Key People / Management

  Alexander Pertsemlidis

Company News

There are no news available.